Schedule 13G ownership disclosure

VITRO DIAGNOSTICS INC

Security class unavailable · CUSIP: 928501303

Event date: 2022-09-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
37,049,318
Percent of class
31.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001954927-23-000001
Form type
SC 13G
Filer
Vitro Biopharma, Inc.
CIK
CIK 793171
Filed
Feb 15, 2023
Reporting period
Sep 09, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub